A French startup company, Kallistem Labroatory, working with a top government lab said it has developed in-vitro human sperm, claiming a breakthrough in infertility treatment sought for more than a decade (translated interview with Marie-Helene Perrard).
In May 2015, Kallistem said it had managed to transform basic male fertility cells, called spermatogonia, into mature sperm in test tubes.
Now Kallistem has released details of the technology known as Artistem®.
Artistem® is an artificial testicle that uses cellular therapy technology which allows germinal stem cells to ‘mature’ and produce, ex vivo (outside the body), fertilizing spermatozoa.
Get updates from The Cardinal ALL NEWS FEEDS on Facebook. Just ‘LIKE’ the ‘Arlington Cardinal Page (become a fan of our page). The updates cover all posts and sub-category posts from The Cardinal — Arlingtoncardinal.com. You can also limit feeds to specific categories. See all of The Cardinal Facebook fan pages at Arlingtoncardinal.com/about/facebook …